About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Astrazeneca Pharma India Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
506820
ISIN Demat
INE203A01020
Book Value
349.12
NSE Code
ASTRAZEN
Dividend Yield %
0.44
Market Cap
203875.00
P/E
108.72
EPS
75.01
Face Value
2
BSE
NSE
08-Jul-2026 16:01
BSE
NSE
NSE F & O
08-Jul-2026 15:43
BSE
NSE
NSE F & O
Last Price
8155.00
Net Change
-45.05
% Change
-0.55%
Prev.Close
8200.05
Open
8200.10
High
8258.35
Low
8125.00
Volume
328
Last Price
8141.00
Net Change
-63
% Change
-0.77%
Prev.Close
8204.00
Open
8204.00
High
8254.00
Low
8114.50
Volume
5014
Value
2674840
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
8258.35
52-Week High
9850.00
52-Week Low
7630.00
Value
40818974
Best Buy
8141.00
Best Sell
0.00
Best Quantity
4
Sell Quantity
0
Today's Range
8254.00
52-Week High
9849.50
52-Week Low
7551.50
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
4
Price
8141.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
03-Sep-18
10-Sep-18
Dividend
1600 %
18-Jul-25
Company News
12-06-2026
AstraZeneca Pharma India ...
11-06-2026
AstraZeneca Pharma India ...
13-04-2026
AstraZeneca Pharma gets n...
13-04-2026
AstraZeneca Pharma surges...
17-03-2026
AstraZeneca Pharma gets n...
11-03-2026
AstraZeneca Pharma India ...
27-02-2026
AstraZeneca Pharma India ...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Scores
|
Policies of JFSL
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
|
Rights and obligation
|
SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
